Blockade to pathological remodeling of infarcted heart tissue using a porcupine antagonist

Jesung Moon1, Huanyu Zhou2,3, Li-Shu Zhang3,4

  • 1Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390.

Insights

Wnt signaling inhibition using Porcupine (Porcn) inhibitors like WNT-974 unexpectedly promotes heart tissue regeneration. This suggests Porcn inhibitors could be developed as antifibrotic agents for cardiac repair after injury.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Molecular Oncology

Background:

  • Secreted Wnt signaling molecules regulate cell fate and tissue regeneration, but also contribute to cancer.
  • Porcupine (Porcn) inhibitors, like WNT-974, are being tested as anticancer agents.
  • The systemic effects of Porcn inhibitors on tissue regeneration are not fully understood.

Purpose of the Study:

  • To systematically assess the effects of the Porcn inhibitor WNT-974 on tissue regeneration.
  • To identify potential unwanted side effects of Porcn inhibitors.
  • To investigate the pro-regenerative effects of Wnt signaling suppression in heart muscle.

Main Methods:

  • Systematic assessment of WNT-974 effects on various tissue types.
  • In vitro cultures of cardiac cell types to delineate Wnt signaling.
  • Analysis of collagen VI (Col6) involvement in cardiac remodeling.
  • Assessment of heart function recovery after myocardial infarction in vivo.

Main Results:

  • WNT-974 induced pro-regenerative responses in heart muscle despite systemic Wnt signaling suppression.
  • Wnt signaling in cardiac cells supports an anti-regenerative program involving collagen VI (COL6A1).
  • WNT-974 treatment improved recovery of heart function post-infarction by reducing scarring and Col6 production.

Conclusions:

  • Porcupine (Porcn) inhibitors can promote cardiac regeneration by mitigating adverse remodeling and fibrosis.
  • Targeting Porcn may offer a therapeutic strategy for promoting heart repair following injury.
  • Porcn inhibitors show potential as antifibrotic agents for cardiovascular applications.

Related Concept Videos